Lumos Diagnostics Holdings (ASX:LDX) EV-to-EBIT : -2.28 (As of Jun. 19, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Lumos Diagnostics Holdings EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Lumos Diagnostics Holdings's Enterprise Value is A$26.68 Mil. Lumos Diagnostics Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-11.70 Mil. Therefore, Lumos Diagnostics Holdings's EV-to-EBIT for today is -2.28.

The historical rank and industry rank for Lumos Diagnostics Holdings's EV-to-EBIT or its related term are showing as below:

ASX:LDX' s EV-to-EBIT Range Over the Past 10 Years
Min: -4.65 Med: 0 Max: 0
Current: -2.28

ASX:LDX's EV-to-EBIT is ranked worse than
100% of 100 companies
in the Medical Diagnostics & Research industry
Industry Median: 20.465 vs ASX:LDX: -2.28

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Lumos Diagnostics Holdings's Enterprise Value for the quarter that ended in Dec. 2023 was A$44.37 Mil. Lumos Diagnostics Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-11.70 Mil. Lumos Diagnostics Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -26.38%.

Lumos Diagnostics Holdings EV-to-EBIT Historical Data

The historical data trend for Lumos Diagnostics Holdings's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumos Diagnostics Holdings EV-to-EBIT Chart

Lumos Diagnostics Holdings Annual Data

Trend

Jun22

Jun23

EV-to-EBIT

-0.44

-1.03

Lumos Diagnostics Holdings Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Lumos Diagnostics Holdings's EV-to-EBIT

For the Diagnostics & Research subindustry, Lumos Diagnostics Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lumos Diagnostics Holdings's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Lumos Diagnostics Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Lumos Diagnostics Holdings's EV-to-EBIT falls into.

Lumos Diagnostics Holdings EV-to-EBIT Calculation

Lumos Diagnostics Holdings's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	26.683	/	-11.703
	=	-2.28

Lumos Diagnostics Holdings's current Enterprise Value is A$26.68 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lumos Diagnostics Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-11.70 Mil.

Lumos Diagnostics Holdings (ASX:LDX) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Lumos Diagnostics Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-11.703	/	44.37
	=	-26.38 %

Lumos Diagnostics Holdings's Enterprise Value for the quarter that ended in Dec. 2023 was A$44.37 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lumos Diagnostics Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-11.70 Mil.

Lumos Diagnostics Holdings EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Lumos Diagnostics Holdings's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Lumos Diagnostics Holdings (ASX:LDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lumos Diagnostics Holdings Ltd (ASX:LDX) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

LDXHF:USA

Address

2724 Loker Ave West, Carlsbad, CA, USA, 92010

Website

https://www.lumosdiagnostics.com

Lumos Diagnostics Holdings Ltd is engaged in the development, manufacture and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests. It also directly develops, manufactures and commercializes proprietary, Lumos-branded POC tests that target infectious and inflammatory diseases. It generates maximum revenue from the commercial services and solutions relating to POC diagnostic tests.

Lumos Diagnostics Holdings (ASX:LDX) Headlines

No Headlines